Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial

Gynecologic Oncology

Volumn 120, Issue 3, 2011, Pages 474-479

  Nyante, Sarah J ^a   Black, Amanda ^a   Kreimer, Aimée R ^a   Duggan, Máire A ^b   Carreon, J Daniel ^a   Kessel, Bruce ^c   Buys, Saundra S ^d   Ragard, Lawrence R ^e   Johnson, Karen A ^a   Dunn, Barbara K ^a   Lamerato, Lois ^f   Commins, John M ^g   Berg, Christine D ^a   Sherman, Mark E ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF HAWAII   (United States)

^d UNIVERSITY OF UTAH   (United States)

^e WESTAT   (United States)

^f HENRY FORD HOSPITAL   (United States)

^g INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

CA 125; False positive; Histopathology; Ovary; Screening; Transvaginal ultrasound

Indexed keywords

ADENOCARCINOMA; ADENOMA; ADENOMYOSIS; ADULT; AGED; ARTICLE; BRENNER TUMOR; CANCER RISK; CANCER SCREENING; COLON CANCER; CYSTADENOMA; DEMOGRAPHY; ENDOMETRIOSIS; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HYDROSALPINX; HYSTERECTOMY; LABORATORY DIAGNOSIS; LEIOMYOMA; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OVARY CANCER; OVARY CYST; OVARY DISEASE; OVARY ENDOMETRIOSIS; OVARY ENDOSALPINGOSIS; OVARY FIBROMA; OVARY HYPERPLASIA; OVARY STROMAL HYPERPLASIA; OVARY TERATOMA; OVARY TUMOR; POLYP; PRIORITY JOURNAL; PROSTATE,LUNG,COLORECTAL AND OVARIAN CANCER SCREENING TRIAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; THECOMA; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CANCER;

AGED; CA-125 ANTIGEN; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MIDDLE AGED; OVARIAN NEOPLASMS; VAGINA;

EID: 79951575830     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.11.015     Document Type: Article

References (26)

1. Jemal A., Siegel R., Ward E., Hao Y., Xu J., and Thun M.J. Cancer statistics, 2009 CA Cancer J Clin 59 4 Jul-Aug. 2009 225 249
2. Horner MJ R.L., Krapcho M., Neyman N., Aminou R., Howlader N., and Altekruse S.F. SEER cancer statistics review, 1975-2006 2009 National Cancer Institute Bethesda, MD
3. S.S. Buys, E. Partridge, M.H. Greene, P.C. Prorok, D. Reding, and T.L. Riley Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial Am J Obstet Gynecol 193 5 Nov. 2005 1630 1639 (Pubitemid 41540458)
4. Kobayashi H., Yamada Y., Sado T., Sakata M., Yoshida S., and Kawaguchi R. A randomized study of screening for ovarian cancer: a multicenter study in Japan Int J Gynecol Cancer 18 3 May-Jun. 2008 414 420
5. U. Menon, A. Gentry-Maharaj, R. Hallett, A. Ryan, M. Burnell, and A. Sharma Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) Lancet Oncol 10 4 Apr. 2009 327 340
6. E. Partridge, A.R. Kreimer, R.T. Greenlee, C. Williams, J.L. Xu, and T.R. Church Results from four rounds of ovarian cancer screening in a randomized trial Obstet Gynecol 113 4 Apr. 2009 775 782
7. van Nagell Jr. J.R., DePriest P.D., Ueland F.R., DeSimone C.P., Cooper A.L., and McDonald J.M. Ovarian cancer screening with annual transvaginal sonography: findings of 25, 000 women screened Cancer 109 9 May 1 2007 1887 1896 (Pubitemid 46668555)
8. P.C. Prorok, G.L. Andriole, R.S. Bresalier, S.S. Buys, D. Chia, and E.D. Crawford Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Control Clin Trials 21 6 Suppl Dec. 2000 273S 309S
9. Y. Zalel, S. Lurie, Y. Beyth, S. Goldberger, and R. Tepper Is it necessary to perform a prophylactic oophorectomy during hysterectomy? Eur J Obstet Gynecol Reprod Biol 73 1 May 1997 67 70 (Pubitemid 27224463)
10. Z. Holub, M. Jandourek, A. Jabor, L. Kliment, and M. Wagnerova Does hysterectomy without salpingo-oophorectomy influence the reoperation rate for adnexal pathology? A retrospective study Clin Exp Obstet Gynecol 27 2 2000 109 112 (Pubitemid 30636278)
11. B. Plockinger, and H. Kolbl Development of ovarian pathology after hysterectomy without oophorectomy J Am Coll Surg 178 6 Jun. 1994 581 585 (Pubitemid 24172565)
12. M.E. Sherman, J.V. Lacey, S.S. Buys, D.J. Reding, C.D. Berg, and C. Williams Ovarian volume: determinants and associations with cancer among postmenopausal women Cancer Epidemiol Biomarkers Prev 15 8 Aug. 2006 1550 1554 (Pubitemid 44299331)
13. E.J. Pavlik, P.D. DePriest, H.H. Gallion, F.R. Ueland, M.B. Reedy, and R.J. Kryscio Ovarian volume related to age Gynecol Oncol 77 3 Jun. 2000 410 412 (Pubitemid 30368559)
14. F. Vural, B. Vural, and I. Yucesoy Reproductive aging and ovarian volume Int J Gynaecol Obstet 91 1 Oct. 2005 73 74 (Pubitemid 41278568)
15. J.L. Bennington, B.R. Ferguson, and S.L. Haber Incidence and relative frequency of benign and malignant ovarian neoplasms Obstet Gynecol 32 5 Nov. 1968 627 632
16. P.P. Koonings, K. Campbell, D.R. Mishell Jr. , and D.A. Grimes Relative frequency of primary ovarian neoplasms: a 10-year review Obstet Gynecol 74 6 Dec. 1989 921 926 (Pubitemid 20003288)
17. J.D. Seidman, and A. Mehrotra Benign ovarian serous tumors: a re-evaluation and proposed reclassification of serous "cystadenomas" and "cystadenofibromas" Gynecol Oncol 96 2 Feb. 2005 395 401 (Pubitemid 40127140)
18. J.T. Comerci Jr. , F. Licciardi, P.A. Bergh, C. Gregori, and J.L. Breen Mature cystic teratoma: a clinicopathologic evaluation of 517 cases and review of the literature Obstet Gynecol 84 1 Jul. 1994 22 28 (Pubitemid 24202950)
19. M.A. Killackey, and R.S. Neuwirth Evaluation and management of the pelvic mass: a review of 540 cases Obstet Gynecol 71 3 Pt 1 Mar. 1988 319 322
20. A. Gadducci, R. Tana, S. Cosio, and A.R. Genazzani The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature Crit Rev Oncol Hematol 66 1 Apr. 2008 10 20 (Pubitemid 351324130)
21. H.H. Chung, J.W. Kim, N.H. Park, Y.S. Song, S.B. Kang, and H.P. Lee Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer Acta Obstet Gynecol Scand 85 12 2006 1501 1505
22. K. Judson, C. McCormick, R. Vang, A.V. Yemelyanova, L.S. Wu, and R.E. Bristow Women with undiagnosed colorectal adenocarcinomas presenting with ovarian metastases: clinicopathologic features and comparison with women having known colorectal adenocarcinomas and ovarian involvement Int J Gynecol Pathol 27 2 Apr. 2008 182 190 (Pubitemid 351450674)
23. J.V. Lacey Jr. , M.E. Sherman, B.B. Rush, B.M. Ronnett, O.B. Ioffe, and M.A. Duggan Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia J Clin Oncol 28 5 Feb 10 2010 788 792
24. J.D. Seidman, R.A. Soslow, R. Vang, J.J. Berman, M.H. Stoler, and M.E. Sherman Borderline ovarian tumors: diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images Hum Pathol 35 8 Aug. 2004 918 933 (Pubitemid 39037176)
25. A. Dorum, G.P. Blom, E. Ekerhovd, and S. Granberg Prevalence and histologic diagnosis of adnexal cysts in postmenopausal women: an autopsy study Am J Obstet Gynecol 192 1 Jan. 2005 48 54 (Pubitemid 40164219)
26. L. Valentin, L. Skoog, and E. Epstein Frequency and type of adnexal lesions in autopsy material from postmenopausal women: ultrasound study with histological correlation Ultrasound Obstet Gynecol 22 3 Sep. 2003 284 289 (Pubitemid 37088554)